FindTrial
Sign In

A randomized, controlled, double-blind, single-center study of methylprednisolone to reduce early postoperative negative behavior in children with obstructive sleep apnea-and hypopnea syndrome (OSAHS)

A randomized, controlled, double-blind, single-center study of methylprednisolone to reduce early postoperative negative behavior (e-PONB) in children with obstructive sleep apnea-and hypopnea syndrome (OSAHS)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014691
Enrollment
Unknown
Registered
2018-01-29
Start date
2018-01-30
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early postoperative negative behavior in children with obstructive sleep apnea-and hypopnea syndrome

Interventions

control group:none
Group 1:Methylprednisolone 1mg/kg
Group 2:Methylprednisolone 2mg/kg

Sponsors

Shanghai Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 7 Years

Inclusion criteria

Inclusion criteria: ASA physical status I or II, aged 3–7 years, undergoing elective subumbilical surgery suitable for regional anesthesia were enrolled?

Exclusion criteria

Exclusion criteria: history of chronic illness, cognitive impairment or risk of malignant hyperthermia.

Design outcomes

Primary

MeasureTime frame
blood glucose;Delirium;restless;Pain;—

Countries

China

Contacts

Public ContactHou Huiyan

Shanghai Children's Medical Center

hhy1225@hotmail.com+86 18601718909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026